These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. FRACTIONATION AND STANDARDIZATION OF PLASMA FIBRINOLYTIC COMPONENTS. MACKAY M Br Med Bull; 1964 Sep; 20():189-94. PubMed ID: 14209757 [No Abstract] [Full Text] [Related]
43. [On practical execution of fibrinolysis therapy with enzyme preparations]. DEUTSCH E; FISCHER M; STACHER A Folia Haematol (Frankf); 1961 Oct; 6():310-7. PubMed ID: 13885851 [No Abstract] [Full Text] [Related]
44. [Research on the inhibitors of fibrinolysis: the methods of measuring antistreptokinase, antiplasmin and antitrypsin]. GIACOMAZZI G Haematol Lat; 1961; 4():255-71. PubMed ID: 13898268 [No Abstract] [Full Text] [Related]
45. THROMBOLYTIC THERAPY. DOUGLAS AS; MCNICOL GP Proc R Soc Med; 1964 Jul; 57(7):609-14. PubMed ID: 14178954 [No Abstract] [Full Text] [Related]
46. [THROMBOLYTIC THERAPY AND CHANGES IN FIBRINOLYTIC ACTIVITY]. DOUGLAS AS; MCNICOL GP Recenti Prog Med; 1964 Sep; 37():189-217. PubMed ID: 14229145 [No Abstract] [Full Text] [Related]
47. THE FIBRINOLYTIC SYSTEM IN HEALTH AND DISEASE. JOHNSON AJ; NEWMAN J Semin Hematol; 1964 Oct; 1():401-31. PubMed ID: 14225683 [No Abstract] [Full Text] [Related]
48. Fibrinolysis and hyphema. The effect of thrombolysin and Kabikinas on clotted blood in camera anterior of the eye in rabbits. HORVEN I Acta Ophthalmol (Copenh); 1962; 40():320-6. PubMed ID: 14449118 [No Abstract] [Full Text] [Related]
49. [Lysis of human blood clots in vitro]. ROSOLLECK H Klin Wochenschr; 1961 Apr; 39():440-4. PubMed ID: 13743567 [No Abstract] [Full Text] [Related]
51. ON THE COMBINED ADMINISTRATION OF STREPTOKINASE AND PANCREATIC TRYPSIN INHIBITOR. VERSTRAETE M; VERMYLEN J; VERMYLEN C; DEVREKER RA Thromb Diath Haemorrh; 1964 Dec; 12():391-5. PubMed ID: 14254698 [No Abstract] [Full Text] [Related]
52. CURRENT APPRAISAL OF THROMBOLYTIC THERAPY. A CRITICAL REVIEW. LIEBERMAN J Calif Med; 1963 Nov; 99(5):301-7. PubMed ID: 14081772 [TBL] [Abstract][Full Text] [Related]
53. FIBRINOGEN BREAKDOWN PRODUCTS. LEWIS JH; WILSON JH Am J Physiol; 1964 Nov; 207():1053-7. PubMed ID: 14237449 [No Abstract] [Full Text] [Related]
54. The effectiveness of activators in clot lysis, with special reference to fibrinolytic therapy. A new method for determination of preformed clot lysis. BLIX S Acta Med Scand Suppl; 1962; 386():1-24. PubMed ID: 13971658 [No Abstract] [Full Text] [Related]
56. EPSILON-AMINOCAPROIC ACID AND OTHER INHIBITORS OF FIBRINOLYSIS. MCNICOL GP; DOUGLAS AS Br Med Bull; 1964 Sep; 20():233-9. PubMed ID: 14209764 [No Abstract] [Full Text] [Related]
57. [Thromboelastographic research on postoperative fibrinolysis activated with streptokinase in prostatectomized subjects]. VENTURA M Minerva Urol; 1959; 11():221-5. PubMed ID: 13841695 [No Abstract] [Full Text] [Related]
58. Analysis of the streptokinase activated fibrinolysis by means of thrombelastography. DE NICOLA P; MAZZETTI GM Blut; 1957 Jan; 3(1):20-6. PubMed ID: 13412773 [No Abstract] [Full Text] [Related]
59. [EXPERIMENTAL CONTRIBUTIONS TO THE DETERMINATION OF THE EFFICIENCY OF METHODS OF STUDYING COAGULATION PHYSIOLOGY. III. ACTIVATION OF THE PROFIBRINOLYTIC SYSTEM BY 2 DIFFERENT STREPTOKINASE PREPARATIONS AND THE STORAGE STABILITY OF ITS COMPONENTS]. BERGHOFF A; GLATZEL H Thromb Diath Haemorrh; 1963 Jul; 143():436-45. PubMed ID: 14081265 [No Abstract] [Full Text] [Related]